Quick Answer
Ping An Biomedical Co., Ltd. reported Operating Income Loss of -$14.70 million for the year ending 2025.
- Ping An Biomedical Co., Ltd. showed a decrease of -720,913.8% in Operating Income Loss from 2024 to 2025.
- This data is from Ping An Biomedical Co., Ltd.'s annual report (Form 10-K), filed with the SEC on January 30, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Ping An Biomedical Co., Ltd.'s Operating Income Loss has declined by 2,500.3%.
- Historical annual values: Fiscal year 2025: -$14.70 million | Fiscal year 2024: -$2.0 thousand | Fiscal year 2023: $612.5 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: